Haemonetics Corp (HAE)
86.22
+1.15
(+1.35%)
USD |
NYSE |
Apr 24, 16:00
86.20
-0.02
(-0.02%)
Pre-Market: 20:00
Haemonetics Cash from Investing (TTM): -327.34M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| December 31, 2023 | -327.34M |
| September 30, 2023 | -94.90M |
| June 30, 2023 | -100.84M |
| March 31, 2023 | -143.79M |
| December 31, 2022 | -160.29M |
| September 30, 2022 | -139.26M |
| June 30, 2022 | -128.71M |
| March 31, 2022 | -86.34M |
| December 31, 2021 | -480.93M |
| September 30, 2021 | -475.05M |
| June 30, 2021 | -417.40M |
| March 31, 2021 | -425.44M |
| December 31, 2020 | -41.48M |
| September 30, 2020 | -51.76M |
| June 30, 2020 | -82.93M |
| March 31, 2020 | -57.18M |
| December 31, 2019 | -25.26M |
| September 30, 2019 | -32.98M |
| June 30, 2019 | -87.02M |
| March 31, 2019 | -116.15M |
| December 31, 2018 | -120.90M |
| September 30, 2018 | -119.61M |
| June 30, 2018 | -86.56M |
| March 31, 2018 | -63.04M |
| December 31, 2017 | -59.64M |
| Date | Value |
|---|---|
| September 30, 2017 | -50.66M |
| June 30, 2017 | -54.66M |
| March 31, 2017 | -73.31M |
| December 31, 2016 | -87.04M |
| September 30, 2016 | -93.36M |
| June 30, 2016 | -100.03M |
| March 31, 2016 | -104.77M |
| December 31, 2015 | -98.10M |
| September 30, 2015 | -104.11M |
| June 30, 2015 | -111.88M |
| March 31, 2015 | -121.77M |
| December 31, 2014 | -130.95M |
| September 30, 2014 | -116.93M |
| June 30, 2014 | -107.20M |
| March 31, 2014 | -105.83M |
| December 31, 2013 | -86.88M |
| September 30, 2013 | -85.56M |
| June 30, 2013 | -622.85M |
| March 31, 2013 | -596.40M |
| December 31, 2012 | -600.29M |
| September 30, 2012 | -598.70M |
| June 30, 2012 | -49.60M |
| March 31, 2012 | -52.20M |
| December 31, 2011 | -46.99M |
| September 30, 2011 | -51.44M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-480.93M
Minimum
Dec 2021
-25.26M
Maximum
Dec 2019
-176.78M
Average
-100.84M
Median
Jun 2023
Cash from Investing (TTM) Benchmarks
| Stryker Corp | -962.00M |
| Boston Scientific Corp | -2.574B |
| Insulet Corp | -119.40M |
| ResMed Inc | -264.75M |
| Masimo Corp | -81.20M |